Clinical trials
Observational Precursor Cell Lymphoblastic Leukemia-Lymphoma trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
82 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 3 |
| 2005 | 1 |
| 2007 | 2 |
| 2009 | 4 |
| 2010 | 6 |
| 2011 | 3 |
| 2012 | 3 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 4 |
| 2018 | 8 |
| 2019 | 7 |
| 2020 | 8 |
| 2021 | 6 |
| 2022 | 4 |
| 2023 | 12 |
| 2024 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 82 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assiut University | 7 |
| National Taiwan University Hospital | 4 |
| Aristotle University Of Thessaloniki | 2 |
| Assistance Publique - Hôpitaux de Paris | 2 |
| Central Hospital, Nancy, France | 2 |
| European Organisation for Research and Treatment of Cancer - EORTC | 2 |
| Gruppo Italiano Malattie EMatologiche dell'Adulto | 2 |
| IRCCS Burlo Garofolo | 2 |
| IRCCS SYNLAB SDN | 2 |
| Istanbul University - Cerrahpasa | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 82 |
| Leukemia, Myeloid, Acute | 9 |
| Leukemia | 4 |
| COVID-19 | 3 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 3 |
| Lymphoma, Non-Hodgkin | 3 |
| Neoplasms | 3 |
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 3 |
| Anemia, Refractory, with Excess of Blasts | 2 |
| Breast Neoplasms | 2 |
Trials
Showing 1 to 25 of 82. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.